Exchange: NYSEArca·Updated 07:30 PM EST

CNBS News

News
all
press releases
US Reclassifies Weed: Can Cannabis ETFs Give Your Portfolio a New High?
Medical marijuana's US reclassification revives cannabis ETFs like WEED, with tax relief and reform hopes fueling sharp gains across the sector.
Zacks
US Reclassifies Weed: Can Cannabis ETFs Give Your Portfolio a New High?
Medical marijuana's US reclassification revives cannabis ETFs like WEED, with tax relief and reform hopes fueling sharp gains across the sector.
Zacks
More News
Tirlay Brands shares have declined 33% year to date.
Stocktwits
CNBS Cannabis ETF climbs to a 52-week high, fueled by rescheduling optimism and potential further gains.
Zacks
The New York City-headquartered pharmaceutical company produces and distributes cannabis for medicinal and adult use.
Stocktwits
Cannabis, metals, space and health care led ETF gains last week. WEED, CNBS, SIL, UFO, GDXJ, PLTM and OZEM outperformed despite tech weakness.
Zacks
Cannabis, space, nat gas & auto led last week's leveraged ETF winners. MSOX, RKLX, KOLD, VOYX and CVNX posted outsized gains despite tech weakness.
Zacks
Cannabis ETFs explode on reform buzz. CNBS, WEED, MSOS and MJ jumped double-digits on Dec. 12, 2025 as Trump reportedly weighs reclassifying marijuana, boosting optimism.
Zacks
Zacks Analyst Blog highlights MSOS, CNBS, WEED, MJ, and YOLO as marijuana ETFs soar over 100% in three months on U.S. legalization hopes and investor optimism.
Zacks
Marijuana ETFs, such as WEED, MSOS, and CNBS, are rebounding as hopes for rescheduling boost investor optimism.
Zacks
ETFs tied to Cannabis, Asia, China, materials and bitcoin miners led August's gains in Wall Street. ETFs like WEED, KSTR, CNXT, GBUG and WGMI won in August.
Zacks

Advertisement|Remove ads.